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Tissue engineering of autologous lung tissue aims to become a therapeutic alternative to transplantation.
Efforts published so far in creating scaffolds have used harsh decellularization techniques that damage
the extracellular matrix (ECM), deplete its components and take up to 5 weeks to perform. The aim of
this study was to create a lung natural acellular scaffold using a method that will reduce the time of
production and better preserve scaffold architecture and ECM components. Decellularization of rat lungs
via the intratracheal route removed most of the nuclear material when compared to the other entry
points. An intermittent inﬂation approach that mimics lung respiration yielded an acellular scaffold in a
shorter time with an improved preservation of pulmonary micro-architecture. Electron microscopy
demonstrated the maintenance of an intact alveolar network, with no evidence of collapse or tearing.
Pulsatile dye injection via the vasculature indicated an intact capillary network in the scaffold.
Morphometry analysis demonstrated a signiﬁcant increase in alveolar fractional volume, with alveolar
size analysis conﬁrming that alveolar dimensions were maintained. Biomechanical testing of the scaf-
folds indicated an increase in resistance and elastance when compared to fresh lungs. Staining and
quantiﬁcation for ECM components showed a presence of collagen, elastin, GAG and laminin. The
intratracheal intermittent decellularization methodology could be translated to sheep lungs, demon-
strating a preservation of ECM components, alveolar and vascular architecture. Decellularization treat-
ment and methodology preserves lung architecture and ECM whilst reducing the production time to 3 h.
Cell seeding and in vivo experiments are necessary to proceed towards clinical translation.
 2013 Elsevier Ltd. All rights reserved.fax: þ44 (0)2074046181.
.
All rights reserved.1. Introduction
Chronic obstructive pulmonary disease (COPD) is the ﬁfth
largest cause of death with a worldwide mortality of 3 million
people annually. Estimates from the World Health Organization
P. Maghsoudlou et al. / Biomaterials 34 (2013) 6638e6648 6639indicate that by 2030, COPD will become the third leading cause of
death [1]. Due to the poor regenerative capability of the lung, the
only deﬁnitive treatment is lung transplantation. However, acute
rejection, graft failure and the need for immunosuppression lead to
a survival of 79% at 1 year, 53% at 5 years, and 30% at 10 years [2].
The development of a tissue-engineered lung that could be trans-
planted without the need for immunosuppression would provide a
therapeutic alternative.
Tissue engineering has already found clinical applications in a
number of organs including the bladder [3], urethra [4], and tra-
chea, both in adults [5,6] and children [7]. However engineering of
complex organs is still limited. When comparing the trachea to the
lung, the latter is more intricate both in function and in structure
leading to greater challenges in its engineering. For this reason, a
handful of efforts in animal models have been unable to yield
considerable progress. The intricacy of the alveolar network, the
alveolus-capillary interface along with the variety of cell types that
populate it, render it difﬁcult to replicate this architecture from the
micro- to the macro-scale. From the material science aspect, three
kinds of scaffold have been used; namely naturally-derived, syn-
thetic, and natural acellular matrices.
Naturally-derived materials have included collagen [8], matrigel
[9], and Gelfoam [10], the latter being a porous form of porcine
gelatin. When Andrade [10] used Gelfoam as a scaffold for fetal rat
lung cells, allowing 7 days of in vitro growth prior to injecting the
construct into the lung parenchyma they demonstrated the
appearance of alveolar-like structures that stained positive for pro-
surfactant protein-C (SP-C), Clara cell secreted protein (CC-10) and
Von Willebrand factor. The regenerated alveoli however, were
present only in the periphery of the sponge and stained poorly for
CellTracker orange, the dye that was used to follow the trans-
planted cells. When the pulmonary artery was injected with India
Ink to evaluate vascularization of the construct there was no evi-
dence of formation of the alveolus-capillary junctions needed for
gas exchange. This study re-afﬁrms the need for a scaffold with an
inherent pulmonary-like micro-architecture.
Synthetic scaffolds that have been employed for lung tissue en-
gineering include PGA-F127 [11], PLA, and PLGA [12]. Cortiella et al.
[11] have combined ovine somatic lung progenitor cells (SLPC) and a
PGA/PF-127 scaffold and implanted the construct on the backs of
nude mice. The constructs developed into alveolar-like structures
thatwere positive for SP-C, CC-10, collagen and smoothmuscle actin.
When these constructs were placed in the space left following a
pneumonectomy in sheep, ﬂeshy vascularized tissue developed,
which however lacked any development of alveolar architecture or
composition despite having adequate blood supply.
The use of natural acellular matrices could solve the issues that
have been encountered so far with animal studies for lung regen-
eration, since in an optimally decellularized lung the hierarchical
pulmonary network and alveolus-capillary junctions would be
preserved. Ott et al. [13] perfused rat lungs via the pulmonary ar-
tery with 0.1% sodium dodecyl sulfate (SDS) (120 min), 1% Triton-X
(10 min) and phosphate buffed saline with antibiotic and anti-
mycotic (PBS/AA) (72 h), a total of 74 h, to obtain decellularized
scaffolds. The scaffolds were seeded with rat fetal lung cells, and
following a left pneumonectomy, were transplanted orthotopically
in rats. Rats with transplanted constructs developed pulmonary
edema following extubation when compared to pneumo-
nectomized controls, even though arterial oxygen tension was
increased. Petersen et al. [14] performed rat lung decellularization
via both the pulmonary artery and trachea using a solution of 8 mM
CHAPS, 1M NaCl, and 25 mM EDTA, followed by PBS/AA, 90 U/ml
endonuclease and PBS containing 10% FBS, with the complete
protocol lasting up to 5 weeks. The scaffold supported cell growth
following seeding with neonatal rat lung epithelial cells andmicrovascular lung endothelial cells. When implanted into rats
in vivo for short time intervals (up to 120min) the engineered lungs
participated in gas exchange even though they inﬂated less than
the native right lung and bleeding occurred in the airways.
Both of the above approaches need reﬁning since they use long
decellulization protocols that would be impractical and difﬁcult to
replicate in humans. Moreover, decellularization protocols that
include extensive use of detergent may lead to the loss of important
information contained in the native tissue. For example, SDS is
known to disrupt tissue ultrastructure [15] and eliminate growth
factors [16]. The development of a brief decellularization technique
that retains ECM architecture without removing growth factors
would be paramount for further in vivo work.
2. Materials and methods
2.1. Harvest of organs
A midline thoracotomy was performed, the muscles of the head and neck
dissected away from themidline and the trachea sectioned above the cricoid cartilage.
The thymus was removed and the pulmonary artery (PA) cannulated via the right
atrium, secured with sutures, ﬂushed with PBS/AA and the inferior and superior vena
cavaewere transected. The lungwasmobilized from the cricoid cartilage and dissected
free from its attachments to the esophagus and thoracic cavity.
2.2. Decellularization
The lung was decellularized using four protocols:
2.2.1. Protocol A (IV)
The pulmonary artery was perfused with continuous ﬂuid delivery using a
Masterﬂex L/S variable speed roller pump at 0.6 ml/min. Each DET cycle was
composed of de-ionized water (resistivity 18.2 MU/cm) at 4 C for 24 h, 4% sodium
deoxycholate (Sigma) at room temperature (RT) for 4 h, and 2000kU DNase-I
(Sigma) in 1M NaCl (Sigma) at RT for 3 h. Up to 4 cycles were carried out.
2.2.2. Protocol B (IT/IV)
The trachea and pulmonary artery were perfused with continuous ﬂuid delivery
using a Masterﬂex L/S variable speed roller pump at 0.6 ml/min. Each DET cycle was
composed of de-ionized water (resistivity 18.2 MU/cm) at 4 C for 24 h, 4% sodium
deoxycholate (Sigma) at room temperature (RT) for 4 h, and 2000kU DNase-I
(Sigma) in 1M NaCl (Sigma) at RT for 3 h. Up to 4 cycles were carried out.
2.2.3. Protocol C (IT)
The trachea was perfused with continuous ﬂuid delivery using a Masterﬂex L/S
variable speed roller pump at 0.6 ml/min. Each DET cycle was composed of de-
ionized water (resistivity 18.2 MU/cm) at 4 C for 24 h, 4% sodium deoxycholate
(Sigma) at room temperature (RT) for 4 h, and 2000kU DNase-I (Sigma) in 1M NaCl
(Sigma) at RT for 3 h. Up to 4 cycles were carried out.
2.2.4. Protocol D (IT/IN)
The tracheawas perfused with intermittent ﬂuid delivery using a syringe pump.
Simulating the inspiratory cycle, each insufﬂation of the syringe pump was followed
up by a withdrawal of the liquid that was infused. Four consecutive insufﬂations
(each lasting 30 s) of each solution (de-ionized water (resistivity 18.2 MU/cm), 4%
sodium deoxycholate (Sigma), and 2000kU DNase-I (Sigma) in 1M NaCl (Sigma)
comprised one DET cycle. Up to 9 cycles were carried out.
In all the protocols after each treatment cycle the constructs were preserved at
4 C, in PBS/AA and analyzed with the following methodologies.
2.3. Histology and immunostaining analysis
Samples were ﬁxed for 24 h in 10% neutral buffered formalin solution in PBS (pH
7.4) at RT. Subsequently they were washed in distilled water (dH2O), dehydrated in
graded alcohol, embedded inparafﬁn and sectioned at 5 mm. Tissue slideswere stained
with hematoxylin and eosin (H&E) (Leica, Germany), Masson’s trichrome (MT), (Leica,
Raymond A Lamb, BDH Chemicals Ltd), elastin Van Gieson (EVG) (VWR, Leica, Ray-
mond A Lamb), and alcian blue (AB) (BDH Chemicals Ltd, Cellpath Ltd) stains. For
immunoﬂuorescence analysis, primary antibodies were used against laminin (Abcam,
UK), collagen I (Abcam, UK), and collagen III (Abcam, UK) respectively, at dilutions of
1:100. The slides were visualized using confocal microscopy (Carl Zeiss).
2.4. DNA quantiﬁcation
DNA was isolated using a tissue DNA isolation kit (PureLink Genomic DNA
MiniKit, Invitrogen) following the manufacturer’s instructions. Brieﬂy, the samples
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were puriﬁed using alcohol washes and measured spectrophotometrically (Nano-
drop). Optical densities at 260 nm and 280 nmwere used to estimate the purity and
yield of nucleic acids.
2.5. GAG quantiﬁcation
The sulfated GAG (GAG) content of native tissue and acellular matrices was
quantiﬁed using the Blyscan GAG Assay Kit (Biocolor, UK). In brief, 50 mg of minced
wet tissue was weighed and placed in a micro-centrifuge tube containing 1 ml of
Papain digestion buffer and incubated in a water bath at 65 C for 18 h, with occa-
sional tube removal and vortexing. Aliquots of each sample were mixed with 1,9-
dimethyl-methylene blue dye and reagents from the GAG assay kit. The absor-
bance at 656 nm was measured spectrophotometrically (Tecan Inﬁnity) and
compared to standards made from bovine tracheal chondroitin-4-sulfate to deter-
mine the GAG content.
2.6. Elastin quantiﬁcation
The elastin content of native tissue and acellular matrices was quantiﬁed using
the FASTIN elastin assay (Biocolor, UK) according to the manufacturer’s instructions.
Brieﬂy, the samples were homogenized, and elastin was solubilized in 0.25 M oxalic
acid. Two consecutive incubations were performed at 95 C to ensure complete
extraction of elastin. Extracts were incubated with 5,10,15,20-tetraphenyl-21H,23H-
porphine tetrasulfonate (TPPS) dye, and absorbance was determined at 555 nm
spectrophotometrically (Tecan Inﬁnity). Elastin concentrations from a standard
curve were used to calculate the elastin content of the tissue.
2.7. Scanning electron microscopy (SEM)
Samples were ﬁxed in 2.5% glutaraldehyde in 0.1 M phosphate buffer and left for
24 h at 4 C. Following washing with 0.1 M phosphate buffer, they were cut into
segments of approximately 1 cm length and cryoprotected in 25% sucrose, 10%
glycerol in 0.05 M PBS (pH 7.4) for 2 h, then fast frozen in Nitrogen slush and frac-
tured at approximately 160 C. The samples were then placed back into the
cryoprotectant at room temperature and allowed to thaw. After washing in 0.1 M
phosphate buffer (pH 7.4), the material was ﬁxed in 1% OsO4/0.1 M phosphate buffer
(pH 7.3) at 3 C for 1½ hours and washed again in 0.1 M phosphate buffer (pH 7.4).
After rinsing with dH2O, specimens were dehydrated in a graded ethanol-water
series to 100% ethanol, critical point dried using CO2 and ﬁnally mounted on
aluminum stubs using sticky carbon taps. The material was mounted to present the
fractured surfaces across the parenchyma to the beam and coatedwith a thin layer of
Au/Pd (approximately 2 nm thick) using a Gatan ion beam coater. Images were
recorded with a Jeol 7401 FEG scanning electron microscope.
2.8. Transmission electron microscopy
Lung samples were cut into segments having a wall of approximately 1 cm in
length. After washing in 0.1 M phosphate buffer (pH 7.4), they were ﬁxed in 1% OsO4/
0.1 M phosphate buffer (pH 7.3) at 3 C for 1½ hours thenwashed in 0.1 M phosphate
buffer (pH 7.4). Specimens were stained en bloc with 0.5% uranyl acetate in dH2O at
3 C for 30 min, rinsed with dH2O, dehydrated in a graded ethanol-water series and
inﬁltrated with Agar 100 resin and then hardened. Sections measuring 1 mm were
cut and stained with 1% toluidine blue in dH2O for lightmicroscopy. A representative
area was selected and sections were cut at 70e80 nm using a diamond knife on a
Reichert ultra-cut Emicrotome. Sections were collected on 200-mesh copper, coated
slot grid and stainedwith uranyl acetate and lead citrate. Imageswere recordedwith
a Joel 1010 transition electron microscope.
2.9. Vascular network imaging
Vascular network imaging was carried out on rat scaffolds that were decellu-
larized using protocol D. Vascular access was obtained by cannulating the pulmo-
nary arteries via the right ventricle. For imaging of the vascular tree, 1% Trypan Blue
(SigmaeAldrich) was perfused into the scaffold at a rate of 2 ml/min. An iPhone 4S
(Apple, US) was used to ﬁlm the infusion and iMovie to separate stillshots.
2.10. Morphometric analysis
For morphometric analysis the standards for quantitative assessment of lung
structure by the American Thoracic Society and European Respiratory Society were
followed [17]. Fresh and decellularized lungs were ﬁxed with 2.5% glutaraldehyde (pH
7.4) by rapid intratrachealﬂowat a head pressure 20e25 cmabove the highest point of
the lung. This ensured homogeneous lung ﬁxation that would preserve ﬁne paren-
chymal architecture. Following ﬁxation, airway inﬂation pressure was maintained for
24 h by tying off the trachea. The samples were then washed in dH2O, dehydrated in
graded alcohol, embedded in parafﬁn and sections were prepared at 5 mm. Tissue
slides were stained with hematoxylin and eosin (H&E) (Leica, Germany) and low
power ﬁeld images were taken (5) of adjacent sections that had 20% overlap. Theimages were stitched together on Fiji using a method that, based on the Fourier Shift
Theorem, computes all possible translations between images and ﬁnds the best
conﬁguration of overlap [18]. Blending was implemented with maximum intensity. A
random offset grid was placed on the images with an area of 5000 mm2. 20 ﬁelds were
randomly selected and processed using point-counting to calculate fractional volumes
of lung parenchyma (Vv(p)), alveolar space (Vv(a)), conducting airway space (Vv(c)),
total airspace (Vv(A)) and alveolar septa (Vv(s)). Vv(p) was calculated in an indirect
manner according to the suggestions of the American Thoracic Society task force on
quantitative lung measurements [17]. Non-parenchymal volume (Vv(non-p)), that is,
bronchioles, vessels, interlobular septa and lymph nodes was counted instead as it
constituted a smaller fraction (about 10%):
Vvðp; LÞ ¼ 1 Pðnon pÞ=PðLÞ
2.11. Alveolar size analysis
A total of 6 images per group (fresh vs. scaffold) containing 650 alveoli eachwere
analyzed so as to examine the difference in alveolar dimension. To this aim, for each
image the alveoli were segmented and their boundaries analytically obtained by
means of an automated procedure as previously described [19,20]. Subsequently, the
shape data were collected, the alveolar area computed and the two groups statis-
tically compared.
2.12. Biomechanical testing
Pulmonary function was measured using the forced oscillation technique as
previously described [21]. Excised rat lungs were cannulated with a 16 gage blunted
needle and attached to a computer controlled piston ventilator (Flexivent, SCIREQ
Inc. Montreal, QE, Canada). Lungs were ventilated at 90 breaths/minute, with a tidal
volume of 2.0 ml, and a positive end expiratory pressure (PEEP) of 3 or 6 cm dH2O.
Pressure was measured at the airway opening and volume is measured as the
displacement of the piston of the ventilator. Lung mechanics were measured by
applying a 2 s perturbation every 10 s for a total of 10 readings at each PEEP setting.
These measurements involve interrupting mechanical ventilation while oscillatory
ﬂow signals are applied to the lung by the ventilator. The ﬂow oscillations are non-
damaging, having amplitudes less than or equal to normal tidal volume, and may
contain small-amplitude frequency components up to 20 Hz. Multiple linear
regression was used to ﬁt measured pressure and volume in each individual mouse
to the model of linear motion of the lung [22,23]. Model ﬁts that resulted in a co-
efﬁcient of determination less than 0.80 were excluded.
2.13. Chicken chorioallantoic membrane (CAM) angiogenic assay
To evaluate the angiogenic properties of the decellularized intestinal tissue
in vivo we used the CAM assay as previously described [24,25]. Fertilized chicken
eggs (Henry Stewart and Co., UK) were incubated at 37 C and constant humidity. At
3 days of incubation an oval window of approximately 3 cm in diameter was cut into
the shell with small dissecting scissors to reveal the embryo and CAM vessels. The
window was sealed with tape and the eggs were returned to the incubator for a
further 5 days. At day 8 of incubation, 1 mm diameter acellular lung matrices (both
rat and sheep samples), or polyester used as a negative control, were placed on the
CAM between branches of the blood vessels. Samples were examined daily until 7
days after placement wherein they were photographed in ovo with a stereomicro-
scope equipped with a Camera System (Leica) to quantify the blood vessels sur-
rounding the matrices. Blood vessels less than 10 mm in diameter converging
toward the tissues were counted by blinded assessors (n ¼ 5), with the mean of the
counts being considered.
3. Results
Decellularization using an intravascular approach from the pul-
monary artery led to a reduction in DNA from 602  145 ng/mg to
114  22 ng/mg (p < 0.05), following 1 cycle of treatment (Fig. 1A).
The incomplete decellularization that was also evident by the pres-
ence of nuclear and cytoplasmic material in H&E and MT staining
(Fig. 1D, G), was not improved with further cycles of treatment.
Decellularization using a combined intravascular-intratracheal
method led to a reduction in DNA from 602  145 ng/mg to
35746 ng/mg (ns) after 1 cycle and 674 ng/mg (p< 0.05) after 2
cycles with no signiﬁcant decrease in 3 and 4 cycles (Fig. 1B). His-
tology conﬁrmed the removal of almost the entirety of nuclear and
cytoplasmic material, with weak cellular staining being present on
the lobar edges (Fig. 1E,H). Similar to the results with intravascular
decellularization, staining with EVG and AB conﬁrmed a
Fig. 1. Decellularization via the vascular route reduces DNA (p < 0.05), following 1 cycle of treatment (A), with histological examination demonstrating an incomplete decellu-
larization with nuclear and cytoplasmic material present (D, G, J, M). Further cycles do not reduce DNA signiﬁcantly further. Decellularization from both vascular and tracheal routes
leads to a reduction in DNA (p < 0.05) after 2 cycles with no signiﬁcant decrease in 3 and 4 cycles (B). Histology conﬁrms the removal of almost the entirety of nuclear and
cytoplasmic material, with weak cellular staining being present on the lobar edges (E, H). Staining with with EVG and AB conﬁrm a preservation of elastin and GAG (K, N).
Decellularization via the tracheal route reduces DNA (p < 0.05) after only 1 cycle of treatment (C). Histology staining conﬁrms an absence of nuclear material (F, I) and maintenance
of elastin and GAG (L, O); IV: Intravascular, IV/IT: intravascular/intratracheal, IT: intratracheal, H&E: hematoxylin and eosin, MT: Masson’s trichrome, EVG: elastin Van Gieson, AB:
alcian blue, *: P < 0.05, y: P < 0.01, all statistical comparisons to fresh tissue, scale bar: 100 mm.
P. Maghsoudlou et al. / Biomaterials 34 (2013) 6638e6648 6641
P. Maghsoudlou et al. / Biomaterials 34 (2013) 6638e66486642preservation of elastin and GAG (Fig.1J, K,M, N). Decellularization via
the intratracheal route reduced DNA from 602  145 ng/mg to
47 9 ng/mg after only 1 cycle of treatment (p< 0.05) (Fig. 1C). H&E
and MT staining conﬁrmed an absence of nuclear material (Fig. 1F,I).
GAG and elastin were maintained as shown by EVG and AB staining
(Fig. 1L, O).
Having established that intratracheal decellularization was su-
perior to both vascular and combined approaches, we investigated
whether intermittent inﬂation rather than continuous perfusion
would further improve the decellularization technique. Indeed,
decellularizing using an intermittent intratracheal inﬂation
approach that mimics lung inspiration and expiration yielded an
acellular scaffold that was macroscopically transparent following 9
cycles of treatment (Fig. 2A). One cycle of decellularization using
this methodology lasts approximately 15 min, with 9 cycles lasting
around 3 h. This compares very well to the continuous method of
decellularization, in which one cycle comprises 31 h. Histological
examination of the scaffolds obtained using intermittent intra-
tracheal inﬂation demonstrated an improved preservation of the
pulmonary architecture with inﬂated alveolar ducts and alveoli,
and walls consisting of a solid collagenous network, in contrast to
collapsed alveoli and thinned-out collagen in continuous intra-
tracheal inﬂation (Fig. 2B). DNAwas reduced from 602 145 ng/mg
to 71  28 ng/mg in intermittent decellularization that was not
signiﬁcantly different to continuous decellularization (Fig. 2C).
SEM of lungs that were decellularized intratracheally, both in a
continuous and an intermittent manner, supported these results.
Interestingly, decellularized lung obtained with continuous inﬂation
showed a scaffold in which the bronchovascular tree and alveolar
network were maintained but in a poor manner following 1 cycle,
due to the loss of connective tissue from the pulmonary ECM
(Fig. 3B,E). In comparison to this, intermittent inﬂation produced
acellular scaffolds in which the bronchopulmonary structures, alve-
olar ducts and alveolar network were completely preserved with an
absence of cell nuclei when examined at higher magniﬁcationsFig. 2. Decellularization using an intermittent intratracheal decellularization methodology
interval when compared to the continous intratracheal protocol. Cellular material is remov
quantiﬁcation; H&E: hematoxylin and eosin, *: P < 0.05, all statistical comparisons to fresh(Fig. 3C,F). TEM of fresh lung showed the alveolar-capillary junction
with red blood cells in close contact with the alveoli (asterisk,
Fig. 3G). Following continuous decellularization, the basement
membrane had ruptured at a number of areas (black arrows, Fig. 3H)
and the collagen ﬁbers were exposed to the alveolus (white arrow,
Fig. 3H). The intermittent approach led to maintenance of the
basement membrane and collagen ﬁbers (Fig. 3I).
We assessed the alveolar and vascular networks of the scaffold
obtained with intermittent decellularization as markers of micro-
architecture maintenance. We injected the pulmonary artery with
trypan blue whilst performing time-lapse microscopy (Suppl. mov.
1). Following injection, the dye distributed in the central areas of the
scaffold ﬁrst (Fig. 4A). As dye approached the periphery the ﬁne
branching of the vascular tree could also be seen (Fig. 4C,D). The clear
edge of the lung was a sign of the lack of leakage from the scaffold
(Fig. 4D). Morphometry analysis of fresh lung and acellular scaffold
(Fig. 4E) demonstrated maintenance of the pulmonary components
alongside a decrease in non-parenchymal volume from 12.1% to
6.15% (P < 0.0001). A signiﬁcant increase was also noted in alveolar
fractional volume with a rise from 32.6% to 37.8% (P < 0.05). A
quantitative analysis of alveolar size showed that the decellularized
alveolar area is reduced together with the variability, therefore the
decellularized area values are included in those of the fresh samples
(Fig. 4F). This suggests that the decellularization process does not
introduce new features in terms of alveolar dimension.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2013.05.015.
Both airway elastance (Fig. 4G) and resistance (Fig. 4H) were
determined at positive end expiratory pressures (PEEP) of 3 and 6 cm
H2O. Decellularized rat lungs showed signiﬁcantly increased airway
resistance and elastance at both PEEP levels (p < 0.05). The resis-
tance values were 0.5  0.3 cm H2O and 4.4  0.7 cm H2O for native
lung and decellularized lung, respectively. The elastance values were
3.8  1.6 cm H2O and 13.1  1.7 cm H2O for native lung and decel-
lularized lung, respectively. No signiﬁcant difference was observedyields an acellular scaffold that is macroscopically transparent (A) in a shorter time-
ed equally well to the continuous methodology as evident by H&E staining and DNA
tissue, scale bar: 100 mm.
Fig. 3. SEM demonstrates that in decellularized lung obtained with continuous inﬂation the bronchovascular tree (A, B) and alveolar network (D, E) are maintained but in a poor
manner with weak collagen ﬁbrils. Scaffolds obtained with intermittent intratracheal inﬂation show a complete preservation of bronchopulmonary structures (A, C), alveolar ducts
and alveolar network (D, F) with an absence of cell nuclei. TEM of fresh lung shows the alveolar-capillary junction with red blood cells in close contact to the alveoli (asterisk, G),
which following continuous decellularization, ruptures at a number of areas (black arrows, H), with exposure of the collagen ﬁbers to the alveolus (white arrow, H). In sharp
contrast, the intermittent approach leads to maintenance of the basement membrane and collagen ﬁbers (I); SEM: scanning electron microscopy, TEM: transmission electron
microscopy.
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lower elastance at a PEEP of 6 cm H2O for decellularized lungs.
MT staining of the scaffolds obtained using intermittent inﬂa-
tion demonstrated a well-structured alveolar network, with pres-
ervation of collagen in both central and peripheral areas (Fig. 5A).
EVG staining indicated preservation of peripheral, axial and septal
elastic ﬁbers (Fig. 5B). Elastin quantiﬁcation demonstrated a major
variability in the elastin content of fresh samples with levels of
0.98  0.98 ng/mg and a progressive non-signiﬁcant reduction to
0.3  0.3 ng/mg at 9 cycles of treatment (Fig. 5D). AB staining
conﬁrmed the preservation of GAG in the lung scaffold following
decellularization (Fig. 5C). The preservation of GAG is conﬁrmed
with quantiﬁcation with content decreasing from 1.6  0.3 ng/mg
to 0.3  0.2 ng/mg, a reduction to 19% of the fresh value (P < 0.01)
(Fig. 5H). Immunoﬂuorescence for collagen I, collagen III and lam-
inin showed good maintenance of the components of the ECM
together with a complete absence of nuclear material as evidenced
by DAPI staining (Fig. 5EeG).
To evaluate the in vivo potential of the scaffold, segments were
placed on top of the chicken chorioallantoic membrane. The scaf-
folds integrated well with the developing environment of the
chicken egg. Representative images of lung tissue placed in ovo at
0 (Fig. 6A), and 7 days (Fig. 6B) of incubation, demonstrated
attraction of blood vessels that, in a spoke-wheel pattern, seem topenetrate the tissue. The polyester control, at the same time-points,
had no effect on vascular development around it (Fig. 6C,D). Seven
days after implantation, the number of vessels converging towards
the lung matrices was signiﬁcantly increased in comparison to the
same samples at day 0 (P < 0.05) and to the polyester membrane
that was used as a negative control (P < 0.01) (Fig. 6E).
To assess whether the described methodology could be used
established for human lungs, we examined its’ efﬁciency in decel-
lularizing sheep lungs. The macroscopic image of the decellularized
scaffold represents a solid mass that maintains the architecture of
the original lung, whilst being transparent indicates a lack of cells
(Fig. 7A). Decellularization was achieved at 12 cycles, indicated by
H&E (Fig. 7B) and DAPI staining (data not shown), which conﬁrmed
the absence of nuclear material. DNA was reduced from
733  305.4 ng/mg to 27.6  9.4 ng/mg (p < 0.05) following 12
cycles (Fig. 7C). SEM showed, similar to the rat scaffold, that there
were no visible cells and there was an excellent preservation of
bronchovascular structures (Fig. 7D), alveolar ducts and network
(Fig. 7E), as well as the capillaries that are in close contact with the
alveoli (asterisk, Fig. 7F). TEM indicated that following decellula-
rization there was complete removal of all cellular material and
maintenance of the basement membrane (Fig. 8A). MT staining
indicated, similarly to the rat scaffold, a hierarchical collagenous
network, in both central as well as peripheral areas (Fig. 8B). EVG
Fig. 4. Pulsatile trypan blue injection of the pulmonary artery demonstrates progressive dye distribution from the central areas of the scaffold (A, B) to the periphery where ﬁne
branching of the capillaries is visible (C, D). Morphometry analysis of fresh lung and acellular scaffold (E) shows a signiﬁcant decrease in non-parenchymal fractional volume
(P < 0.001) and a corresponding increase in alveolar fractional volume (P < 0.05). Quantitative analysis of alveolar size indicates no differences in alveolar dimension following
decellularization (F). Decellularized rat lungs show signiﬁcantly increased airway elastance (G) and elastance (H) at positive end expiratory pressures (PEEP) of 3 and 6 cm H2O
(p < 0.05); N: non-parenchymal fractional volume, S: septal fractional volume, A: alveolar space fractional volume, C: conducting airway fractional volume, AU: arbitrary units,
*: P < 0.05, z: P < 0.001, all statistical comparisons to fresh tissue, scale bar: 100 mm.
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Fig. 5. MT staining demonstrates a hierarchical alveolar network, with preservation of collagen in both central and peripheral areas (A). EVG and AB staining show preservation of
elastic ﬁbers and GAG (B, C). Immunoﬂuorescence for collagen I, collagen III and laminin shows maintenance of the ECM components with no DAPI staining in the scaffolds when
compared to fresh tissue (EeG). GAG quantiﬁcation demonstrates a reduction to 19% of the fresh value (P < 0.01) (H); MT: Masson’s trichrome, EVG: elastin Van Gieson, AB: alcian
blue, GAG: glycosaminoglycans *: P < 0.05, y: P < 0.01, all statistical comparisons to fresh tissue, scale bar: 100 mm.
P. Maghsoudlou et al. / Biomaterials 34 (2013) 6638e6648 6645staining displayed an excellent preservation of elastin (Fig. 8C). On
the other hand, AB staining showed weaker staining compared to
the rat scaffold (Fig. 8D). However, GAG quantiﬁcation demon-
strated preservation of GAG, with a non-signiﬁcant decrease from
0.84  0.3 ng/mg to 0.44  0.1 ng/mg, a reduction to 52% of the
fresh value (Fig. 8E).
4. Discussion
Lung tissue engineering has had limited successful applications
because of the difﬁculties associated with recreating the intricacy
of the bronchioalveolar network and the alveolus-capillary inter-
face. Given the range of scaffolds currently available, the category
that holds the most potential in recreating this complex three-
dimensional architecture is that of natural acellular matrices.
However, efforts to produce an optimal acellular matrix have used
long and harsh decellularization protocols [26,27]. In this study,
using a simple, clinically applicable methodology, we were able to
achieve complete decellularization of both rat and sheep lungs
whilst maintaining their microarchitecture.
We ﬁrst established that intra-tracheal was the optimal entry
site for decellularization which was obtained in just 1 cycle. On thecontrary intravascular access did not lead to complete decellulari-
zation at 4 cycles of treatment, and the combination of vascular and
tracheal access required 2 cycles. Early protocols used simple im-
mersion of the lungs in a series of detergents for an extended
period of time until cells were removed [28]. More recently, the
focus has shifted towards dynamic protocols, in which the trachea
and the pulmonary artery are used to infuse the decellularization
solutions [13,14,29,30]. Other laboratories have used both ports of
entry with complex systems, which, if translated to clinical prac-
tice, could be prone to contamination. Similar to our ﬁndings,
Cortiella et al. [31] omitted the vascular access and used only the
trachea to decellularize rat lungs. However, while they took 7
weeks to obtain efﬁcient decellularization, using our detergent-
enzymatic method (deionized water, sodium deoxycholate,
DNase) we were able to reduce this to just 31 (continuous perfu-
sion) and 3 (intermittent perfusion) hours respectively. Even in a
large animal model such as the sheep wewere able to demonstrate
that complete decellularization was achieved within 6 h using an
intermittent perfusion.
Importantly, all approaches retained ECM components, even
though, using continuous perfusion, pulmonary micro-architecture
maintenance was not optimal as evidenced by areas of tearing and
Fig. 6. The angiogenic properties of the scaffold are demonstrated in vivo following
placement on top of the chicken chorioallantoic membrane. On days 7 after implan-
tation, the number of vessels converging towards the lung matrices is signiﬁcantly
increased in comparison to the same samples at day 0 (P < 0.05) and to the polyester
membrane that was used as a negative control (P < 0.01) (A). Representative images of
lung tissue placed in ovo at 0 (B), and 7 days (C) Of incubation, indicate attraction of
blood vessels that, in a cogwheel fashion, seem to penetrate the tissue. The polyester
control, at the same time-points, has no effect on vascular development around it (D,E);
*: P < 0.05, comparison to scaffold, day 0 x: P < 0.01, comparison to control, day 7.
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using intermittent inﬂation with DET, mimicking an inspiratory/
expiratory system. Interestingly, while histology did not demon-
strate any differences, SEM revealed a structure that had weak
alveolar walls with thinned-out collagen. With all of the articles on
lung decellularized scaffolds not demonstrating results from SEM at
a high magniﬁcation to assess structure, it may be important for
future studies to utilize this methodology as a qualitative assess-
ment for reﬁning the decellularization protocol.
Morphometric analysis of fresh lung and acellular scaffold
indicated a decrease in non-parenchymal volume and an increase
in alveolar fractional volume. The former may be explained due to
the inability to identify acellular non-parenchymal structures such
as blood vessels and lymph nodes during point-counting of the
scaffold. The alveolar fractional volume increase, which waspreviously encountered in SDS-treated scaffolds [13], may be
attributed to the higher possibility of point-counting the alveolar
space when the volume occupied by alveolar cells (included in the
alveolar septal fractional volume) is lost due to decellularization.
We were interested to assess whether the increase in alveolar
fractional volume could be due to an alteration in its’ shape brought
about by decellularization. A non-stereological quantitative evalu-
ation of the alveolar size in fresh and decellularized lungs high-
lighted that in the two groups the alveolar dimension is
comparable. Similarly to previous reports, the decellularized rat
lungs showed similar increases in airway resistance and elastance
[29,31,32]. However, no negative values for resistance were
encountered, as has been the case with CHAPS- and SDS-treated
lungs, an occurrence that was attributed to leakage during the
oscillatory perturbations. Interestingly, the increase in elastance
was PEEP-independent, with no signiﬁcant differences observed
between 3 and 6 cm H2O. Such results may demonstrate that the
alveoli have collapsed and no further tension may recruit them.
Addition of surfactant in mouse decellularized lungs reduced ela-
stance and brought about PEEP-responsiveness and may be
considered in the future for decellularized human lungs [29].
Nevertheless, relevant information obtained through mechanical
analysis may be important for future studies to assess the biome-
chanics of the decellularized lungs and monitor whether preser-
vation of the ECM components has any effect on scaffold elastance
and resistance.
These properties may eventually be regulated by the preserva-
tion of the ECM components. Pulmonary ECM is mainly composed
of collagen, elastin, laminin, GAG, ﬁbronectin, entactin and tenascin
Ref. [33]. We corroborated the results in preservation of architec-
ture and presence of elastin and GAG. The levels of elastin preser-
vation are similar to published protocols and are highly important
in the eventual pulmonary dynamics of the repopulated scaffold.
GAG maintenance is important, as it has been suggested that this
could favorably inﬂuence cell attachment and proliferation.
Immunoﬂuorescence for laminin, collagen I and III in the scaffolds
demonstrated preservation compared to fresh tissue, whilst there
was an absence of cellular material as evidenced by DAPI. Other
components, such as vascular pro-angiogenic factors were evalu-
ated using an established in vivo CAM assay. When placed on top of
the chicken chorioallantoic membrane, vessels were seen
converging towards the scaffold in a circular fashion. This could be
extremely relevant for endothelial cell seeding and neo-capillary
formation in the engineered lung. All these characteristics are
important but irrelevant if not reproducible in a lung that has
similar dimensions and anatomical characteristics to the human
one.
Previous work done for other organs, such as the kidney [34],
liver [35], heart [36], trachea [7,37,38] and esophagus [39] has scaled
up scaffolds for clinical translation. We thus observed that this
methodology could be scaled up to a large animalmodel for the lung.
Decellularizationwas achieved in a higher number of cycles aswould
be expected, but, similarly to the experiments in rat lung, the
decellularization process removed almost the entirety of nuclear and
cytoplasmic material whilst maintaining the pulmonary architec-
ture. SEM conﬁrmed the preservation of capillaries that were frac-
tionated on the interface with the alveoli. Relevant to the clinical
application of this approach was the fact that with these larger lungs
there was an improved preservation of the ECM components. For
example, TEM indicated an improved conservation of large collagen
bundles, whilst elastin and GAG quantiﬁcation demonstrated non-
signiﬁcant reductions to the levels in the scaffold when compared
to fresh tissue.
The golden chalice of this work is a scaffold populated by
recipient cells, able to be transplanted and to function. Future
Fig. 7. The decellularized sheep scaffold represents a solid mass that maintains the architecture of the original lung, whilst being transparent indicating a lack of cells (A).
Decellularization is achieved at 12 cycles with H&E (B) and DNA analysis (P < 0.05) conﬁrming the absence of nuclear material. SEM shows no visible cells and preservation of
bronchovascular structures (D), alveolar ducts and network (E), as well as the capillaries that are in close contact with the alveoli (asterisk, F); *: P < 0.05, all statistical comparisons
to fresh tissue, scale bar: 100 mm.
Fig. 8. TEM shows maintenance of the basement membrane and collagen ﬁbrils (A). MT staining indicates, similarly to the rat scaffold, a hierarchical collagenous network (B). EVG
and AB staining display preservation of elastin and GAG (C, D). GAG quantiﬁcation demonstrates a non-signiﬁcant decrease in GAG values when compared to fresh tissue (E); H&E:
hematoxylin and eosin, MT: Masson’s trichrome, EVG: elastin Van Gieson, AB: alcian blue, GAG: glycosaminoglycans, SEM: scanning electron microscopy, TEM: transmission
electron microscopy, *: P < 0.05, y: P < 0.01, all statistical comparisons to fresh tissue, scale bar: 100 mm.
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population of the scaffold with lung progenitor cells. Subse-
quently, we envisage transplantation of the scaffolds following
pneumonectomy in animal models.
5. Conclusions
We have previously published on the beneﬁts of using the
detergent-enzymatic treatment (DET) for the creation of tracheal,
intestinal and esophageal natural acellular matrices. We have now
established a methodology that produces a pulmonary natural
acellular matrix that preserves the microarchitecture of the tissue
both in the vascular and bronchial counterparts. The production of
the scaffold is a quick process at less than 3 h, and can be scaled up
to a larger animal with similar results. Similarly to what we have
shown for other organs, we were able to establish for the lung a
quick protocol that avoids harsh chemicals that were deemed a
necessity for complex organs thus far.
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